Antimicrobial nanoemulsion compositions and methods

Details Antimicrobial nanoemulsion compositions and methods Antimicrobial nanoemulsion compositions and methods

2002-06-25

2010-02-02

Fubara, Blessing M (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Biocides; animal or insect repellents or attractants

C514S642000, C424S400000

Reexamination Certificate

active

07655252

ABSTRACT:
The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs.

REFERENCES:
patent: 3864472 (1975-02-01), Pensak et al.
patent: 4262007 (1981-04-01), Sherrill
patent: 4895452 (1990-01-01), Yiournas et al.
patent: 5073372 (1991-12-01), Turner et al.
patent: 5103497 (1992-04-01), Hicks
patent: 5108660 (1992-04-01), Michael
patent: 5188822 (1993-02-01), Viccaro et al.
patent: 5368837 (1994-11-01), Baker et al.
patent: 5405604 (1995-04-01), Hall
patent: 5510104 (1996-04-01), Allen
patent: 5547677 (1996-08-01), Wright
patent: 5549901 (1996-08-01), Wright
patent: 5576016 (1996-11-01), Amselem et al.
patent: 5618840 (1997-04-01), Wright
patent: 5651959 (1997-07-01), Hill et al.
patent: 5656280 (1997-08-01), Herb et al.
patent: 5662932 (1997-09-01), Amselem et al.
patent: 5662957 (1997-09-01), Wright
patent: 5698219 (1997-12-01), Valdivia et al.
patent: 5700679 (1997-12-01), Wright
patent: 5709879 (1998-01-01), Barchfeld et al.
patent: 5716637 (1998-02-01), Anselem et al.
patent: 5902227 (1999-05-01), Rivas
patent: 5951988 (1999-09-01), Vittel-van den Hurk et al.
patent: 5961970 (1999-10-01), Lowell et al.
patent: 6015832 (2000-01-01), Baker, Jr. et al.
patent: 6113921 (2000-09-01), Friedman et al.
patent: 6117415 (2000-09-01), Schwarz
patent: 6147047 (2000-11-01), Robbins et al.
patent: 6165500 (2000-12-01), Cevc
patent: 6299884 (2001-10-01), Van Nest et al.
patent: 6335022 (2002-01-01), Simonnet et al.
patent: 6337324 (2002-01-01), Harmenberg et al.
patent: 6348187 (2002-02-01), Pan et al.
patent: 6348503 (2002-02-01), Squires
patent: 6355229 (2002-03-01), Adamy
patent: 6361787 (2002-03-01), Shaheen et al.
patent: 6391288 (2002-05-01), Miyazawa et al.
patent: 6440429 (2002-08-01), Torizuka et al.
patent: 6506803 (2003-01-01), Baker et al.
patent: 6559189 (2003-05-01), Baker et al.
patent: 6635676 (2003-10-01), Baker et al.
patent: 6667276 (2003-12-01), Maier et al.
patent: 6720001 (2004-04-01), Chen et al.
patent: 6761914 (2004-07-01), Deckers et al.
patent: 6790435 (2004-09-01), Ma et al.
patent: 6793929 (2004-09-01), Bleckmann et al.
patent: 6797685 (2004-09-01), Zhu et al.
patent: RE39264 (2006-09-01), Harmenberg et al.
patent: 7314624 (2008-01-01), Baker et al.
patent: 2002/0155084 (2002-10-01), Roessler et al.
patent: 2003/0171344 (2003-09-01), Lekare
patent: 2003/0175221 (2003-09-01), Gers-Barlag et al.
patent: 2004/0043041 (2004-03-01), Baker et al.
patent: 2004/0258701 (2004-12-01), Dominowski et al.
patent: 2005/0013868 (2005-01-01), Brynjelsen et al.
patent: 2005/0196416 (2005-09-01), Kipp et al.
patent: 2006/0100288 (2006-05-01), Bague et al.
patent: 2006/0110415 (2006-05-01), Gupta
patent: 199 18 324 (2000-10-01), None
patent: 0 278 996 (1988-08-01), None
patent: 0 832 649 (1998-04-01), None
patent: 761202 (1999-06-01), None
patent: 806894 (2002-06-01), None
patent: 1561457 (2005-01-01), None
patent: 1 655 021 (2006-05-01), None
patent: WO 94/26252 (1994-11-01), None
patent: WO 95/31966 (1995-10-01), None
patent: WO 96/23409 (1996-08-01), None
patent: WO 96/33725 (1996-09-01), None
patent: WO 00/64429 (2000-11-01), None
patent: WO 01/91728 (2001-12-01), None
patent: WO 02/080864 (2002-10-01), None
patent: WO 2006/035416 (2006-04-01), None
Alasri et al., “Sporicidal properties of peracetic acid and hydrogen peroxide, alone and in combination, in comparison with chlorine and formaldehyde for ultrafiltration membrane disinfection.”Can. J. Microbiol1993: 39: 52-60.
Barrett and Inglis “Growth purification and titration of influenza viruses.” In: Mahy WJ. ed. Virology. a Practical approach. IRL. Press, 1985; 119-151.
Baragi et al., “Transplantation of transdiced Chondrocytes protects articular cartilage from intedeukin 1 -induced extracellular matrix degradation.” J Clin Invest 1995; 96: 2454-2460.
Beauchamp et al., “A critical review of the toxicology of glutaraldphyde.”Crit. Rev. Toxicol. 1992; 22:143-174.
Berkelman et al.,“Emerging infectious diseases in the United States. 1993.”J Infect Dis. Aug. 1994; 170(2):272-7.
Burdon et al., “Experimental infection of mice withBacillus cereus: studies of pathogenesis and pathologic changes.”J. Infect. Dis. 1967; 117: 307-316.
Burdon and Wende. “On the differentiation of anthrax bacilli fromBacillus cereus.” J. Infect. Dis. 1960; 107: 224-234.
Chatlyyne et al., “A lipid emulsion with effective virucidal activity against H IV-1 and other common viruses.”Foundation forRetrovirologyand Human Health, 3rd Conference on Retroviruses and Opportunistic Infections, Washington D.C., U.S.A., 1996: Abstract #351.
Dragon and Rennie “The ecology of anthrax spores: Tough but not invincible.”Can. Vet. J. 1995. 1995; 36: 295-301.
Drobniewski “Bacillus cereusand related species.”Clin. Microbiol. Rev. 1993: 6: 324-338.
Eriksson et al., “Virus validation of plasma-derived products produced by Pharmacia, with particular reference to immuno Globulins.”BloodCoagulationand Fibtinolysis1994; 5 (Suppl. 3): S37-S44.
Florence “Non-ionic surfactant vesicles: preparation and characterization.” In:. Gregoriadis G. ed. LiposomeTechnology. Liposome Preparations and Related Techniques. 2nd ed. vol. 1. CRC Press, 1993.
Foster and Johnstone “Pulling the trigger: the mechanism of bacterial spore germination.”MolecularMicrobiology1990;4:137-141.
Franz et al., “Clinical recognition and management of patients exposed to biological warfare agents.”JAMA1997: 278: 399-411.
Fritz et al. “Pathology of experimental anthrax in'the rhesus monkey.”Lab. Invest. 1995; 73: 691-702.
Goodman & Gilman's “7he Pharmacological Basis of Therapeutics” Eds. Hardman et al., 9th Edition, Pubi. McGraw Hill, 1996; chapters 43 through 50.
Graham et al.. “Characteristics of a human cell line transformed by DNA from human adenovirus type 5.”J Gen Virol1977; 36: 59-74.
Halvorson and Church, Bacteriol Rev 1957, 21:112.
Hamouda et al., “Microbiocidal effects of liposome-like microemulsions on pathogenic Gram negative bacteria.” In: American Society forMicrobiology. 98th General Meeting, Atlanta, Georgia, U.S.A., 1998; Abstract A-52.
Hamouda et al., “A novel surfactant nanoemulsion with broad-spectrum sporicidal activity againstBacillusspecies”. Journal Infectious Disease 1999. 180:1939-1949.
Hayden et al. “Plaque inhibition assay for drug susceptibility testing of influenza viruses.”Antimicrob Agents Chemother. 1980 17: 865-870.
Herlocher et al., “Sequence comparison of AIAA/6/60 influenza viruses: mutations, which may contribute to attenuation.”Virus Res. 1996; 42:11-25.
Hermonat et al.. “The spermicide nonoxyno1-9 does not inactivate papillomavirus.”Sexually Trans Dis1992; 19: 203-205.
Hess et al., “Epidermal toxicity of disinfectants.”Amer. J. Dent. 1991; 4: 51-56.
Hills,J Gen Microbiol4:38,1950.
Horowitz et al., “Solvent/detergent-treated plasma: a vi rus-in activated substitute for fresh frozen plasma.”Blood1992; 79: 826-831.
Huang et al., “Antiviral activity of some natural and synthetic sugar analogues.”FEBSLetters. 1991; 291: 199-202.
Ivins et al.,“Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosolBacillus anthracis sporechallenge in guinea pigs.”Vaccine1995; 13: 1779-1784.
Jackson et al., “PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: The presence of multipleBacillus anthracis strainsin 10 different victims.”PNAS1998;95:1224-1229

Affiliated with

Also associated with

Rating

Antimicrobial nanoemulsion compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antimicrobial nanoemulsion compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial nanoemulsion compositions and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4150365